Display options
Cite
Palleria C, Di Paolo A, Giofrè C, et al. Pharmacokinetic drug-drug interaction and their implication in clinical management. J Res Med Sci. 2013;18(7):601-10
Palleria, C., Di Paolo, A., Giofrè, C., Caglioti, C., Leuzzi, G., Siniscalchi, A., De Sarro, G., & Gallelli, L. (2013). Pharmacokinetic drug-drug interaction and their implication in clinical management. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 18(7), 601-10.
Palleria, Caterina, et al. "Pharmacokinetic drug-drug interaction and their implication in clinical management." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 18,7 (2013): 601-10.
Palleria C, Di Paolo A, Giofrè C, Caglioti C, Leuzzi G, Siniscalchi A, De Sarro G, Gallelli L. Pharmacokinetic drug-drug interaction and their implication in clinical management. J Res Med Sci. 2013 Jul;18(7):601-10. PMID: 24516494; PMCID: PMC3897029.
Copy Download .nbib Format: NLM
Share it on

J Res Med Sci. 2013 Jul;18(7):601-10.

Pharmacokinetic drug-drug interaction and their implication in clinical management.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Caterina Palleria, Antonello Di Paolo, Chiara Giofrè, Chiara Caglioti, Giacomo Leuzzi, Antonio Siniscalchi, Giovambattista De Sarro, Luca Gallelli

Affiliations

  1. Department of Health Science, School of Medicine, University of Catanzaro, Rete Regionale di Informazione Sul Farmaco, AO MaterDomini Catanzaro, Italy.
  2. Department of Clinical and Experimental Medicine, Division of Pharmacology, University of Pisa, Italy.
  3. Azienda Sanitaria Provinciale Catanzaro, Department of Primary Care, Italy.
  4. Department of Neurology, Cosenza Hospital, Italy.

PMID: 24516494 PMCID: PMC3897029

Abstract

Drug-drug interactions (DDIs) are one of the commonest causes of medication error in developed countries, particularly in the elderly due to poly-therapy, with a prevalence of 20-40%. In particular, poly-therapy increases the complexity of therapeutic management and thereby the risk of clinically important DDIs, which can both induce the development of adverse drug reactions or reduce the clinical efficacy. DDIs can be classify into two main groups: pharmacokinetic and pharmacodynamic. In this review, using Medline, PubMed, Embase, Cochrane library and Reference lists we searched articles published until June 30 2012, and we described the mechanism of pharmacokinetic DDIs focusing the interest on their clinical implications.

Keywords: Absorption; adverse drug reaction; distribution; drug-drug interactions; excretion; metabolism; poly-therapy

References

  1. Prog Liver Dis. 1995;13:101-23 - PubMed
  2. Drug Saf. 2007;30(10):911-8 - PubMed
  3. JAMA. 2009 Mar 4;301(9):937-44 - PubMed
  4. Annu Rev Pharmacol Toxicol. 1998;38:389-430 - PubMed
  5. Br J Clin Pharmacol. 1987 Aug;24(2):213-20 - PubMed
  6. J Clin Invest. 1987 Oct;80(4):1029-36 - PubMed
  7. Clin Drug Investig. 2005;25(7):485-90 - PubMed
  8. Clin Pharmacol Ther. 1985 Oct;38(4):402-8 - PubMed
  9. Drug Metabol Drug Interact. 2010;25(1-4):17-24 - PubMed
  10. J Clin Hypertens (Greenwich). 2009 Dec;11(12):738-42 - PubMed
  11. Psychosomatics. 2007 Jan-Feb;48(1):79-85 - PubMed
  12. Clin Pharmacokinet. 1976;1(5):351-72 - PubMed
  13. Ther Drug Monit. 1993 Oct;15(5):375-9 - PubMed
  14. Eur J Clin Pharmacol. 1983;25(2):215-22 - PubMed
  15. Ann Pharmacother. 2011 Jun;45(6):e33 - PubMed
  16. Br J Clin Pharmacol. 1996 Nov;42(5):642-4 - PubMed
  17. J Pharm Sci. 1976 Sep;65(9):1285-91 - PubMed
  18. BMJ. 1997 Oct 25;315(7115):1096-9 - PubMed
  19. Eur J Clin Pharmacol. 1993;45(3):287-9 - PubMed
  20. Br J Clin Pharmacol. 1997 Nov;44(5):499-504 - PubMed
  21. Transplant Proc. 1994 Oct;26(5):2823-4 - PubMed
  22. Clin Pharmacokinet. 1992 Aug;23(2):106-31 - PubMed
  23. Eur J Clin Pharmacol. 2001 Mar;56(12):935-41 - PubMed
  24. Neoplasia. 2011 Mar;13(3):217-29 - PubMed
  25. Pharmacol Res. 2003 Jun;47(6):493-9 - PubMed
  26. Clin Drug Investig. 2012 Dec;32(12):827-33 - PubMed
  27. Clin Pharmacokinet. 1996 Oct;31(4):309-24 - PubMed
  28. DNA Cell Biol. 1993 Jan-Feb;12(1):1-51 - PubMed
  29. Pharmacol Res. 2002 Nov;46(5):395-400 - PubMed
  30. FASEB J. 1992 Jan 6;6(2):745-8 - PubMed
  31. Drug Metab Dispos. 1998 Jul;26(7):609-16 - PubMed
  32. Ann Pharmacother. 2008 Jun;42(6):893-7 - PubMed
  33. Cancer. 1994 Aug 1;74(3):834-41 - PubMed
  34. Clin Pharmacokinet. 2010 Aug;49(8):509-33 - PubMed
  35. Drug Metab Dispos. 1996 Oct;24(10):1121-3 - PubMed
  36. DNA Cell Biol. 1991 Jan-Feb;10(1):1-14 - PubMed
  37. Epilepsia. 1996 Mar;37(3):253-7 - PubMed
  38. Clin Pharmacokinet. 1992 Aug;23(2):132-46 - PubMed
  39. Br J Clin Pharmacol. 2006 Nov;62(5):582-90 - PubMed
  40. J Pharmacol Exp Ther. 2012 Feb;340(2):393-403 - PubMed
  41. Antimicrob Agents Chemother. 1993 Jul;37(7):1426-31 - PubMed
  42. Eur J Clin Pharmacol. 2010 Feb;66(2):137-44 - PubMed
  43. Ann Pharmacother. 1995 Jun;29(6):603-9 - PubMed
  44. Med Pregl. 2000 May-Jun;53(5-6):266-71 - PubMed
  45. Pharm Res. 1995 Nov;12(11):1642-6 - PubMed
  46. PLoS One. 2011;6(7):e22163 - PubMed
  47. Clin Drug Investig. 2007;27(2):115-22 - PubMed
  48. Ann Pharmacother. 2010 Dec;44(12):2031-4 - PubMed
  49. Drug Metabol Drug Interact. 2009;24(1):83-7 - PubMed
  50. Clin Exp Pharmacol Physiol. 1997 Jul;24(7):465-70 - PubMed
  51. Pharmacol Res. 2004 Jan;49(1):85-91 - PubMed
  52. Br J Clin Pharmacol. 2000 Aug;50(2):99-107 - PubMed
  53. Drugs. 2011 Oct 1;71(14):1839-64 - PubMed
  54. Cancer Res. 2011 Apr 15;71(8):3029-41 - PubMed
  55. Pharmacotherapy. 1997 Sep-Oct;17(5):917-28 - PubMed
  56. Rev Enferm. 2011 Sep;34(9):24-31 - PubMed
  57. Yale J Biol Med. 1996 May-Jun;69(3):203-9 - PubMed
  58. Res Commun Mol Pathol Pharmacol. 2000 Nov-Dec;108(5-6):311-23 - PubMed
  59. Epilepsia. 1995;36 Suppl 5:S8-13 - PubMed
  60. Clin Pharmacokinet. 1982 Jan-Feb;7(1):23-41 - PubMed
  61. Drugs. 1982 Aug;24(2):133-9 - PubMed
  62. Mol Pharmacol. 1975 Nov;11(6):824-32 - PubMed
  63. J Pharm Pharmacol. 2007 Nov;59(11):1463-71 - PubMed
  64. Clin Pharmacol Ther. 1984 Dec;36(6):724-30 - PubMed
  65. Ann Pharmacother. 2008 Mar;42(3):434-8 - PubMed
  66. Clin Drug Investig. 2012 Sep 1;32(9):583-92 - PubMed
  67. Clin Pharmacokinet. 1987 May;12(5):321-66 - PubMed
  68. Arch Intern Med. 2000 Oct 9;160(18):2819-22 - PubMed
  69. Clin Pharmacokinet. 1996 Feb;30(2):141-79 - PubMed
  70. Arch Gerontol Geriatr. 2007;44 Suppl 1:199-206 - PubMed
  71. Chem Biol Interact. 1997 Nov 6;107(1-2):17-30 - PubMed
  72. Br J Clin Pharmacol. 1996 Aug;42(2):157-62 - PubMed
  73. Eur J Clin Pharmacol. 1996;50(1-2):139-45 - PubMed
  74. J Heart Lung Transplant. 2011 Feb;30(2):124-35 - PubMed
  75. J Pharmacol Exp Ther. 1997 Jul;282(1):294-300 - PubMed
  76. Hepatology. 1996 Oct;24(4):796-801 - PubMed
  77. Pharmacotherapy. 2007 Jun;27(6):825-34 - PubMed
  78. J Med Chem. 2011 Jul 14;54(13):4548-58 - PubMed
  79. Am J Cardiol. 1999 Oct 1;84(7):811-5 - PubMed
  80. Drug Metab Dispos. 2000 Nov;28(11):1303-10 - PubMed
  81. Pharmacol Res. 2012 Feb;65(2):171-5 - PubMed
  82. Ann Stomatol (Roma). 2011 Jul;2(3-4 Suppl):3-24 - PubMed
  83. Drug Metab Dispos. 2002 Jan;30(1):13-9 - PubMed
  84. Biol Pharm Bull. 2002 Jun;25(6):695-704 - PubMed
  85. Drug Saf. 1994 Oct;11(4):242-51 - PubMed
  86. Antimicrob Agents Chemother. 2009 Mar;53(3):958-66 - PubMed
  87. Drug Saf. 2003;26(1):13-21 - PubMed
  88. J Clin Psychopharmacol. 1994 Apr;14(2):90-8 - PubMed
  89. Clin Pharmacokinet. 1992 Jan;22(1):47-65 - PubMed
  90. J Am Coll Cardiol. 2008 Jan 22;51(3):256-60 - PubMed
  91. Clin Ther. 2010 Mar;32(3):597-606 - PubMed
  92. Lancet. 1985 Nov 9;2(8463):1056-8 - PubMed
  93. J Clin Pharmacol. 2011 Jul;51(7):1071-8 - PubMed
  94. Intern Emerg Med. 2013 Apr;8(3):205-10 - PubMed

Publication Types